Device To Detect Or Measure Nucleic Acid From Viruses Associated With Head And Neck Cancers
OJY · Class II — Moderate Risk (510(k) clearance required) · Microbiology · 21 CFR 866.3236
Classification
FDA Product Code
OJY
Device class
Class II — Moderate Risk (510(k) clearance required)
Regulation
21 CFR 866.3236
Review panel
MI
Medical specialty
Microbiology
Submission type
1
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
N
Definition
A device to detect or measure nucleic acid from viruses associated with head and neck cancers is an in vitro diagnostic test for prescription use in the detection of viral nucleic acid in nasopharyngeal or oropharyngeal cellular specimens from patients with signs and symptoms of head and neck cancer. The test result is intended to be used in conjunction with other clinical information to aid in assessing the clinical status of virus-associated head and neck cancers and/or the likelihood that head and neck cancer is present.